# myBiometry

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mybiometry

- Industry: Medical Devices & Equipment
- Headquarters: Lowell, US
- Website: www.mybiometry.com
- Total disclosed funding: $5M
- Latest round: Seed (Aug 16, 2024)
- Investors on record: 3

## About

Based in Lowell, US, and founded in 2013 by CEO Bryan Nolan, Biometry Inc., d.b.a. myBiometry operates as a health-tech company that specializes in asthma management through advanced health technology. In August 2024, Biometry Inc. raised USD 4.98 million in seed funding led by Dexcom Ventures, with participation from Caresource Management Group and Elevate Ventures.

The company’s core product offering includes a sensor that measures airway inflammation via fractional exhaled nitric oxide (FeNO), enabling the biological assessment of asthma attack risks, medication adherence, and exposure to environmental triggers. The accompanying mobile application functions as a comprehensive monitoring tool, integrating clinical and environmental risk factors to identify the root causes of asthma symptoms and poor control. Targeting patients with asthma, caregivers, and healthcare providers, myBiometry’s services are designed to be scalable and accessible, offering guideline-based self-management programs recognized by the CDC. 

The revenue model of myBiometry is based on a subscription service model, where patients and healthcare providers can access the app and associated services for a recurring fee. The company engages directly with consumers, as well as healthcare organizations, to facilitate user adoption and integrate its technology into existing asthma management protocols. The flagship product, which includes the sensor and the mobile app, is expected to be bundled in various pricing tiers to accommodate different user needs, including individual subscriptions for patients and enterprise solutions for healthcare providers. 

The company plans to use its proceeds from August 2024 funding to o advance the development of its fenoTRACK device and prepare for regulatory submission.

## Funding rounds

- Seed, Aug 16, 2024, $5M — Elevate Ventures, CareSource, Dexcom Ventures

## Investors

- Elevate Ventures (https://capitalatlas.ai/funds/elevate-ventures) — Seed
- CareSource — Seed
- Dexcom Ventures (https://capitalatlas.ai/funds/dexcom-ventures) — Seed